196 related articles for article (PubMed ID: 28376491)
1. Glycobiology Modifications in Intratumoral Hypoxia: The Breathless Side of Glycans Interaction.
Silva-Filho AF; Sena WLB; Lima LRA; Carvalho LVN; Pereira MC; Santos LGS; Santos RVC; Tavares LB; Pitta MGR; Rêgo MJBM
Cell Physiol Biochem; 2017; 41(5):1801-1829. PubMed ID: 28376491
[TBL] [Abstract][Full Text] [Related]
2. Protein glycosylation in cancers and its potential therapeutic applications in neuroblastoma.
Ho WL; Hsu WM; Huang MC; Kadomatsu K; Nakagawara A
J Hematol Oncol; 2016 Sep; 9(1):100. PubMed ID: 27686492
[TBL] [Abstract][Full Text] [Related]
3. On the trail of the glycan codes stored in cancer-related cell adhesion proteins.
Hoja-Łukowicz D; Przybyło M; Duda M; Pocheć E; Bubka M
Biochim Biophys Acta Gen Subj; 2017 Jan; 1861(1 Pt A):3237-3257. PubMed ID: 27565356
[TBL] [Abstract][Full Text] [Related]
4. Sialylation and glycosylation modulate cell adhesion and invasion to extracellular matrix in human malignant lymphoma: Dependency on integrin and the Rho GTPase family.
Suzuki O; Abe M; Hashimoto Y
Int J Oncol; 2015 Dec; 47(6):2091-9. PubMed ID: 26497328
[TBL] [Abstract][Full Text] [Related]
5. Regulatory role of glycans in the control of hypoxia-driven angiogenesis and sensitivity to anti-angiogenic treatment.
Croci DO; Cerliani JP; Pinto NA; Morosi LG; Rabinovich GA
Glycobiology; 2014 Dec; 24(12):1283-90. PubMed ID: 25117007
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the metastatic cell phenotype by sialylated glycans.
Schultz MJ; Swindall AF; Bellis SL
Cancer Metastasis Rev; 2012 Dec; 31(3-4):501-18. PubMed ID: 22699311
[TBL] [Abstract][Full Text] [Related]
7. Glycans and cancer: role of N-glycans in cancer biomarker, progression and metastasis, and therapeutics.
Taniguchi N; Kizuka Y
Adv Cancer Res; 2015; 126():11-51. PubMed ID: 25727145
[TBL] [Abstract][Full Text] [Related]
8. Aiming at the sweet side of cancer: aberrant glycosylation as possible target for personalized-medicine.
Padler-Karavani V
Cancer Lett; 2014 Sep; 352(1):102-12. PubMed ID: 24141190
[TBL] [Abstract][Full Text] [Related]
9. Increased alpha2,6 sialylation of N-glycans in a transgenic mouse model of hepatocellular carcinoma.
Pousset D; Piller V; Bureaud N; Monsigny M; Piller F
Cancer Res; 1997 Oct; 57(19):4249-56. PubMed ID: 9331085
[TBL] [Abstract][Full Text] [Related]
10. Stage Dependence, Cell-Origin Independence, and Prognostic Capacity of Serum Glycan Fucosylation, β1-4 Branching, β1-6 Branching, and α2-6 Sialylation in Cancer.
Ferdosi S; Rehder DS; Maranian P; Castle EP; Ho TH; Pass HI; Cramer DW; Anderson KS; Fu L; Cole DEC; Le T; Wu X; Borges CR
J Proteome Res; 2018 Jan; 17(1):543-558. PubMed ID: 29129073
[TBL] [Abstract][Full Text] [Related]
11. Tumour suppressor p16(INK4a) - anoikis-favouring decrease in N/O-glycan/cell surface sialylation by down-regulation of enzymes in sialic acid biosynthesis in tandem in a pancreatic carcinoma model.
Amano M; Eriksson H; Manning JC; Detjen KM; André S; Nishimura S; Lehtiö J; Gabius HJ
FEBS J; 2012 Nov; 279(21):4062-80. PubMed ID: 22943525
[TBL] [Abstract][Full Text] [Related]
12. MALDI Mass Spectrometry Imaging of N-Linked Glycans in Cancer Tissues.
Drake RR; Powers TW; Jones EE; Bruner E; Mehta AS; Angel PM
Adv Cancer Res; 2017; 134():85-116. PubMed ID: 28110657
[TBL] [Abstract][Full Text] [Related]
13. Glycosylation and Integrin Regulation in Cancer.
Marsico G; Russo L; Quondamatteo F; Pandit A
Trends Cancer; 2018 Aug; 4(8):537-552. PubMed ID: 30064662
[TBL] [Abstract][Full Text] [Related]
14. A recombinant fungal lectin for labeling truncated glycans on human cancer cells.
Audfray A; Beldjoudi M; Breiman A; Hurbin A; Boos I; Unverzagt C; Bouras M; Lantuejoul S; Coll JL; Varrot A; Le Pendu J; Busser B; Imberty A
PLoS One; 2015; 10(6):e0128190. PubMed ID: 26042789
[TBL] [Abstract][Full Text] [Related]
15. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism.
Hakomori S
Cancer Res; 1996 Dec; 56(23):5309-18. PubMed ID: 8968075
[TBL] [Abstract][Full Text] [Related]
16. Importance of altered glycoprotein-bound N- and O-glycans for epithelial-to-mesenchymal transition and adhesion of cancer cells.
Lange T; Samatov TR; Tonevitsky AG; Schumacher U
Carbohydr Res; 2014 May; 389():39-45. PubMed ID: 24491280
[TBL] [Abstract][Full Text] [Related]
17. Hypoxic regulation of glycosylation via the N-acetylglucosamine cycle.
Shirato K; Nakajima K; Korekane H; Takamatsu S; Gao C; Angata T; Ohtsubo K; Taniguchi N
J Clin Biochem Nutr; 2011 Jan; 48(1):20-5. PubMed ID: 21297907
[TBL] [Abstract][Full Text] [Related]
18. Tumor cell N-glycans in metastasis.
Laidler P; Lityńska A
Acta Biochim Pol; 1997; 44(2):343-57. PubMed ID: 9360725
[TBL] [Abstract][Full Text] [Related]
19. The cancer glycome: carbohydrates as mediators of metastasis.
Glavey SV; Huynh D; Reagan MR; Manier S; Moschetta M; Kawano Y; Roccaro AM; Ghobrial IM; Joshi L; O'Dwyer ME
Blood Rev; 2015 Jul; 29(4):269-79. PubMed ID: 25636501
[TBL] [Abstract][Full Text] [Related]
20. Recent progress and new perspectives in lymphoma glycobiology.
Suzuki O; Abe M
Fukushima J Med Sci; 2013; 59(1):1-14. PubMed ID: 23842509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
